1. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 (vol 29, pg 2388, 2008). European Journal of Heart Failure. Jan 2009;11(1):110-110.
2. Berry C, Murdoch DR, McMurray JJV. Economics of chronic heart failure. European Journal of Heart Failure. June 1, 2001 2001;3(3):283-291.
3. McKee PA, Castelli WP, McNamara PM, Kannel WB. The Natural History of Congestive Heart Failure: The Framingham Study. New England Journal of Medicine.
1971;285(26):1441-1446.
4. McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD.
Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. Journal of the American College of Cardiology. 2002;39(1):60-69.
5. Bundkirchen A, Schwinger RHG. Epidemiology and economic burden of chronic heart failure. European Heart Journal Supplements. Aug 2004;6(D):D57-D60.
6. Ross JS, Chen J, Lin Z, et al. Recent National Trends in Readmission Rates After Heart Failure Hospitalization. Circulation: Heart Failure. January 1, 2010 2010;3(1):97-103.
7. Ross Js MGKSB, et al. Statistical models and patient predictors of readmission for heart failure: A systematic review. Archives of Internal Medicine. 2008;168(13):1371-1386.
8. Krumholz HM, Parent EM, Tu N, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Archives of Internal Medicine. Jan 13 1997;157(1):99-104.
9. Michalsen A, König G, Thimme W. Preventable causative factors leading to hospital admission with decompensated heart failure. Heart. November 1, 1998 1998;80(5):437-441.
10. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A MULTIDISCIPLINARY INTERVENTION TO PREVENT THE READMISSION OF ELDERLY PATIENTS WITH CONGESTIVE-HEART-FAILURE. New England Journal of Medicine. Nov 2 1995;333(18):1190-1195.
11. Krumholz HM, Amatruda J, Smith GL, et al. Randomized trial of an education and support intervention to preventreadmission of patients with heart failure. J Am Coll Cardiol. January 2, 2002 2002;39(1):83-89.
12. Investigators G. Randomised trial of telephone intervention in chronic heart failure: DIAL trial. BMJ. 2005-08-18 00:00:00 2005;331(7514):425.
13. Cleland JGF, Louis AA, Rigby AS, Janssens U, Balk A, Investigators T-H. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death - The trans-European network-home-care management system (TEN-HMS) study.
Journal of the American College of Cardiology. May 17 2005;45(10):1654-1664.
14. Maric B, Kaan A, Ignaszewski A, Lear SA. A systematic review of telemonitoring technologies in heart failure. European Journal of Heart Failure. May 2009;11(5):506-517.
15. Chaudhry SI, Wang Y, Concato J, Gill TM, Krumholz HM. Patterns of weight change preceding hospitalization for heart failure. Circulation. Oct 2 2007;116(14):1549-1554.
16. Goldberg LR, Piette JD, Walsh MN, et al. Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: The Weight Monitoring in Heart Failure (WHARF) trial. American Heart Journal. Oct 2003;146(4):705-712.
17. Kimmelstiel C, Levine D, Perry K, et al. Randomized, controlled evaluation of short- and long-term benefits of heart failure disease management within a diverse provider network - The SPAN-CHF trial. Circulation. Sep 14 2004;110(11):1450-1455.
18. Lewin J, Ledwidge M, O'Loughlin C, McNally C, McDonald K. Clinical deterioration in established heart failure: What is the value of BNP and weight gain in aiding diagnosis?
European Journal of Heart Failure. Oct 2005;7(6):953-957.
19. Zhang J, Goode KM, Cuddihy PE, Cleland JGF, Investigators T-H. Predicting hospitalization due to worsening heart failure using daily weight measurement: analysis of the Trans-European Network-Home-Care Management System (TEN-HMS) study.
European Journal of Heart Failure. Apr 2009;11(4):420-427.
20. Chaudhry SI, Mattera JA, Curtis JP, et al. Telemonitoring in Patients with Heart Failure.
New England Journal of Medicine. Dec 9 2010;363(24):2301-2309.
21. Jung W, Rillig A, Birkemeyer R, Miljak T, Meyerfeldt U. Advances in remote monitoring of implantable pacemakers, cardioverter defibrillators and cardiac resynchronization therapy systems. Journal of Interventional Cardiac Electrophysiology. Oct 2008;23(1):73-85.
22. Burri H, Senouf D. Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators. Europace. Jun 2009;11(6):701-709.
23. Varma N, Epstein AE, Irimpen A, Schweikert R, Love C, Investigators T. Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) Trial. Circulation. Jul 27 2010;122(4):325-U328.
24. Varma N, Michalski J, Epstein AE, Schweikert R. Automatic Remote Monitoring of Implantable Cardioverter-Defibrillator Lead and Generator Performance / Clinical Perspective. Circulation: Arrhythmia and Electrophysiology. October 1, 2010 2010;3(5):428-436.
25. Lazarus A. Remote, Wireless, Ambulatory Monitoring of Implantable Pacemakers, Cardioverter Defibrillators, and Cardiac Resynchronization Therapy Systems: Analysis of a Worldwide Database. Pacing and Clinical Electrophysiology. 2007;30:S2-S12.
26. Lieback A, Proff J, Wessel K, Fleck E, Götze S. Remote monitoring of heart failure patients using implantable cardiac pacing devices and external sensors: results of the Insight-HF study. Clinical Research in Cardiology. 2012/02/01 2012;101(2):101-107.
27. 1994 Revisions to Classification of Functional Capacity and Objective Assessment of Patients With Diseases of the Heart. Circulation. 1994;90(1):644-645.
28. Members ATF, Dickstein K, Cohen-Solal A, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).
European Heart Journal. October 1, 2008 2008;29(19):2388-2442.
29. Alt E, Heinz S. Schrittmacher- und Defibrillatortherapie des Herzens 1.: Grundlagen und Anwendung. Schrittmachertherapie: Spitta Verlag GmbH & Company; 1997.
30. Mahaux V, Verboven Y, Waleffe A, Grodent C, Geradin P, Kulbertus H. In Vitro Evaluation of a Sensor Sensitive to Acceleration Forces Included in a New Rate Modulated Pacemaker. Pacing and Clinical Electrophysiology. 1992;15(11):1867-1872.
31. Alt E, Matula M, Theres H, Heinz M. [Principle of the activity-controlled rate-adaptive cardiac pacemaker: analysis of stress and environment-induced mechanical effects on the human body]. Z Kardiol. 1989;78(9):587-597.
32. Smulyan H, Safar ME. Systolic Blood Pressure Revisited. Journal of the American College of Cardiology. 1997;29(7):1407-1413.
33. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is Pulse Pressure Useful in Predicting Risk for Coronary Heart Disease?: The Framingham Heart Study. Circulation.
July 27, 1999 1999;100(4):354-360.
34. Stevenson LW, Perloff JK. The Limited Reliability of Physical Signs for Estimating Hemodynamics in Chronic Heart Failure. JAMA: The Journal of the American Medical Association. February 10, 1989 1989;261(6):884-888.
35. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New England Journal of Medicine. Mar 21 2002;346(12):877-883.
36. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. New England Journal of Medicine. Jan 20 2005;352(3):225-237.
37. Silbernagl PDmS, Despopoulos A. Taschenatlas Physiologie. Vol 8. Auflage: Georg Thieme Verlag; 2012.
38. Jackson G, Gibbs CR, Davies MK, Lip GYH. Pathophysiology. BMJ. 2000-01-15 00:00:00 2000;320(7228):167-170.
39. Packer M. The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure. Journal of the American College of Cardiology.
1992;20(1):248-254.
40. Eisenhofer G, Friberg P, Rundqvist B, et al. Cardiac Sympathetic Nerve Function in Congestive Heart Failure. Circulation. May 1, 1996 1996;93(9):1667-1676.
41. Nolan J, Batin PD, Andrews R, et al. Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart). Circulation. October 13, 1998 1998;98(15):1510-1516.
42. Casolo G, Balli E, Taddei T, Amuhasi J, Gori C. Decreased spontaneous heart rate variability in congestive heart failure. The American journal of cardiology.
1989;64(18):1162-1167.
43. Stein PK, Bosner MS, Kleiger RE, Conger BM. Heart rate variability: A measure of cardiac autonomic tone. American Heart Journal. 1994;127(5):1376-1381.
44. Nolan J, Flapan AD, Capewell S, MacDonald TM, Neilson JM, Ewing DJ. Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function. British Heart Journal. June 1, 1992 1992;67(6):482-485.
45. Oeff M, Kotsch P, Gößwald A, Wolf U. Überwachung multipler Herzkreislaufparameter mittels Telemonitoring bei Patienten mit chronischer Herzinsuffizienz.
Herzschrittmachertherapie und Elektrophysiologie. 2005;16(3):150-158.
46. Koehler F, Winkler S, Schieber M, et al. Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study. Circulation. May 3 2011;123(17):1873-1880.
47. C IS, A CR, A MF, et al.: Structured telephone support or telemonitoring programmes for patients with chronic heart failure. : Inglis Sally C, Clark Robyn A, McAlister Finlay A, Ball Jocasta, Lewinter Christian, Cullington Damien, Stewart Simon, Cleland John GF.
Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database of Systematic Reviews: Reviews 2010 Issue 8 John Wiley & Sons, Ltd Chichester, UK DOI: 10.1002/14651858.CD007228.pub2. 2010.
48. Dunlay SM, Redfield MM, Weston SA, et al. Hospitalizations After Heart Failure Diagnosis A Community Perspective. Journal of the American College of Cardiology.
Oct 27 2009;54(18):1695-1702.
49. Adamson PB, Smith AL, Abraham WT, et al. Continuous autonomic assessment in patients with symptomatic heart failure - Prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation. Oct 19 2004;110(16):2389-2394.
50. Perego GB, Landolina M, Vergara G, et al. Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization. Journal of Interventional Cardiac Electrophysiology. Dec 2008;23(3):235-242.
51. Yu CM, Wang L, Chau E, et al. Intrathoracic impedance monitoring in patients with heart failure - Correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation. Aug 9 2005;112(6):841-848.
52. Abraham WT, Compton S, Haas G, et al. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST). Congestive heart failure (Greenwich, Conn.). 2011 2011;17(2):51-55.
53. Vollmann D, Nagele H, Schauerte P, et al. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. European Heart Journal. 2007-Aug 2007;28(15):1835-1840.
54. Santini M, Ricci RP, Lunati M, et al. Remote monitoring of patients with biventricular defibrillators through the CareLink system improves clinical management of arrhythmias and heart failure episodes. Journal of Interventional Cardiac Electrophysiology. Jan 2009;24(1):53-61.
55. Catanzariti D, Lunati M, Landolina M, et al. Monitoring Intrathoracic Impedance with an Implantable Defibrillator Reduces Hospitalizations in Patients with Heart Failure. Pace-Pacing and Clinical Electrophysiology. Mar 2009;32(3):363-370.
56. Adamson PB, Magalski A, Braunschweig F, et al. Ongoing right ventricular hemodynarnics in heart failure - Clinical value of measurements derived from an implantable monitoring system. Journal of the American College of Cardiology. Feb 19 2003;41(4):565-571.
57. Bourge RC, Abraham WT, Adamson PB, et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure - The COMPASS-HF study. Journal of the American College of Cardiology. Mar 18 2008;51(11):1073-1079.
58. Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. The Lancet.
2011;377(9766):658-666.
59. Whellan DJ, Ousdigian KT, Al-Khatib SM, et al. Combined Heart Failure Device Diagnostics Identify Patients at Higher Risk of Subsequent Heart Failure Hospitalizations: Results From PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) Study. Journal of the American College of Cardiology. 2010;55(17):1803-1810.
60. Sack S, Wende CM, Nägele H, et al. Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study. European Journal of Heart Failure. September 1, 2011 2011;13(9):1019-1027.
61. Fonarow GC, Yancy CW, Heywood JT, for the ADHERE Scientific Advisory Committee SG, Investigators. Adherence to Heart Failure Quality-of-Care Indicators in US Hospitals:
Analysis of the ADHERE Registry. Arch Intern Med. July 11, 2005 2005;165(13):1469-1477.
62. Stewart S, Marley JE, Horowitz JD. Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study. Lancet. Sep 25 1999;354(9184):1077-1083.
63. Koelling TM, Johnson ML, Cody RJ, Aaronson KD. Discharge education improves
clinical outcomes in patients with chronic heart failure. Circulation. Jan 18 2005;111(2):179-185.
64. Stewart S, Vandenbroek AJ, Pearson S, Horowitz JD. Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among patients with congestive heart failure. Archives of Internal Medicine. Feb 8 1999;159(3):257-261.
65. Schoenfeld MH, Compton SJ, Mead RH, et al. Remote monitoring of implantable cardioverter defibrillators: A prospective analysis. Pace-Pacing and Clinical Electrophysiology. Jun 2004;27(6):757-763.
66. Brugada P. What evidence do we have to replace in-hospital implantable cardioverter defibrillator follow-up? Clinical Research in Cardiology. 2006;95(0):iii3-iii9.
67. Raatikainen MJP, Uusimaa P, van Ginneken MME, Janssen JPG, Linnaluoto M. Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving, and cost-effective means for follow-up. Europace. Oct 2008;10(10):1145-1151.
68. Crossley GH, Boyle A, Vitense H, Chang Y, Mead RH. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) Trial: The Value of Wireless Remote Monitoring With Automatic Clinician Alerts. Journal of the American College of Cardiology. 2011;57(10):1181-1189.
69. Landolina M, Perego GB, Lunati M, et al. Remote Monitoring Reduces Healthcare Use and Improves Quality of Care in Heart Failure Patients With Implantable Defibrillators:
The Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators (EVOLVO) Study. Circulation. June 19, 2012 2012;125(24):2985-2992.
70. Mabo P, Victor F, Bazin P, et al. A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial). Eur Heart J. May 2012;33(9):1105-1111.
71. Nielsen JC, Kottkamp H, Zabel M, et al. Automatic home monitoring of implantable cardioverter defibrillators. Europace. Jun 2008;10(6):729-735.
72. Tracy CM, Epstein AE, Darbar D, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. Oct 2 2012;60(14):1297-1313.
73. Ricci RP, Morichelli L, Santini M. Home monitoring remote control of pacemaker and implantable cardioverter defibrillator patients in clinical practice: impact on medical management and health-care resource utilization. Europace. February 1, 2008 2008;10(2):164-170.
74. Vitaphone. http://www.vitaphone.de/home/home/.
75. SHL Telemedizin. http://www.shl-telemedizin.de/.
76. Sanvartis. http://www.sanvartis.de/home.html.
77. Getemed. http://www.getemed.net/?L=1&R=1.
78. Weltärzteverband Handbuch der Deklarationen 2008. http://www.bundesaerztekamm er.de/downloads/handbuchwma.pdf.
79. Deharo JC, Djiane P. Home Monitoring: what can we expect in the future? Clinical Research in Cardiology. 2006;95(0):iii36-iii39.
80. Kern B-R. Zur Zulässigkeit der ärztlichen Behandlung im Internet. MedR. 2001/10/01 2001;19(10):495-498.
Eidesstattliche Versicherung
„Ich, Ann Lieback, versichere an Eides statt durch meine eigenhändige Unterschrift, dass ich die vorgelegte Dissertation mit dem Thema:
Insight-HF Studie Telemonitoring externer Sensoren und Home Monitoring bei Herzinsuffizienz-Patienten
selbstständig und ohne nicht offengelegte Hilfe Dritter verfasst und keine anderen als die angegebenen Quellen und Hilfsmittel genutzt habe.
Alle Stellen, die wörtlich oder dem Sinne nach auf Publikationen oder Vorträgen anderer Autoren beruhen, sind als solche in korrekter Zitierung (siehe „Uniform Requirements for Manuscripts (URM)“ des ICMJE -www.icmje.org) kenntlich gemacht. Die Abschnitte zu Methodik (insbesondere praktische Arbeiten, Laborbestimmungen, statistische Aufarbeitung) und Resultaten (insbesondere Abbildungen, Graphiken und Tabellen) entsprechen den URM (s.o) und werden von mir verantwortet.
Meine Anteile an etwaigen Publikationen zu dieser Dissertation entsprechen denen, die in der untenstehenden gemeinsamen Erklärung mit dem Betreuer, angegeben sind.
Sämtliche Publikationen, die aus dieser Dissertation hervorgegangen sind und bei denen ich Autor bin, entsprechen den URM (s.o) und werden von mir verantwortet.
Die Bedeutung dieser eidesstattlichen Versicherung und die strafrechtlichen Folgen einer unwahren eidesstattlichen Versicherung (§156,161 des Strafgesetzbuches) sind mir bekannt und bewusst.“
Datum Unterschrift
Anteilserklärung an etwaigen erfolgten Publikationen
Ann Lieback hatte folgenden Anteil an den folgenden Publikationen:
Publikation: Ann Lieback, Jochen Proff, Kai Wessel, Eckart Fleck, Stephan Götze, Remote monitoring of heart failure patients using implantable cardiac pacing devices and external sensors: results of the Insight-HF study Clinical Research in Cardiology 2012; 101(2):101-107
Posterpräsentation: auf der 77. Jahrestagung der Deutschen Gesellschaft für Kardiologie 04/2011
„Telemonitoring externer Sensoren und Home Monitoring bei Herzinsuffizienz Patienten“. A.Lieback, J. Proff, E.Fleck, S.Götze
Beitrag im Einzelnen: Beteiligung an der Studie im Rahmen der Promotionsleistung.
Verfassung der Publikation, Erstellung des Posters und Präsentation.
Unterschrift, Datum und Stempel des betreuenden Hochschullehrers
Unterschrift des Doktoranden/der Doktorandin
Danksagung
Ich möchte mich zu allererst bei meinem Betreuer PD Dr. S. Götze für die ausgezeichnete Anleitung und die zahlreichen wertvollen Hinweise bei der Bearbeitung des Forschungsthemas bedanken. Er war für Fragen immer zur Stelle, stets geduldig in den fachlichen Diskussionen und half mir, Tiefpunkte zu überwinden. In ihm fand ich einen Betreuer, der mich hervorragend unterstützte. Durch ihn wurde das wissenschaftliche Arbeiten eine sehr positive Erfahrung.
Den Herren Jochen Proff und Kai Wessel des Sponsors Biotronik gilt mein Dank als wertvolle wissenschaftliche Ansprechpartner.
Herrn Prof. Dr. med. Eckart Fleck danke ich für die konstruktiven Gedanken bei der Bearbeitung des Themas.
Ebenfalls möchte ich meiner Mutter für ihre kontinuierliche Unterstützung und die wichtigen Ratschläge bei der Dissertation danken.